Krystal Biotech Inc

KRYSStocksBiotechnologyUnited StatesNasdaqUSD

Price

$331.58

Today

+1.3%

YTD

+34.8%

About

Krystal Biotech Inc is a biopharmaceutical firm that operates from the US and is dedicated to the development and commercialisation of novel treatments for patients suffering from dermatological diseases. Its work spans across the globe, targeting a variety of medical markets and conditions. Krystal Biotech is a key player in the gene therapy field. Its services encompass creating innovative treatments for debilitating skin diseases using cutting-edge technology. Stay up to date on the share price of KRYS by adding it to your eToro watchlist.

Price chart

Closing price history for KRYS (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)41.96

P/S (TTM)23.30

P/B (TTM)7.29

Market cap$9.91B

Cap tierMid-cap

Industry avg P/E-2.16

Profitability

Gross margin93.31%

EBIT margin44.89%

Net margin45.94%

ROE20.12%

ROA18.30%

Earnings & Revenue

Revenue (TTM)$440.48M

Revenue growth (1Y)+22.6%

EPS (TTM)$7.98

Free cash flow$257.78M

Total debt$8.85M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.98

Employees295

Next earnings2 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.